What basal ganglia changes underlie the parkinsonian state? The significance of neuronal oscillatory activity

Neurobiol Dis. 2013 Oct:58:242-8. doi: 10.1016/j.nbd.2013.05.010. Epub 2013 May 30.

Abstract

One well accepted functional feature of the parkinsonian state is the recording of enhanced beta oscillatory activity in the basal ganglia. This has been demonstrated in patients with Parkinson's disease (PD) and in animal models such as the rat with 6-hydroxydopamine (6-OHDA)-induced lesion and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated monkeys, all of which are associated with severe striatal dopamine depletion. Neuronal hyper-synchronization in the beta (or any other) band is not present despite the presence of bradykinetic features in the rat and monkey models, suggesting that increased beta band power may arise when nigro-striatal lesion is advanced and that it is not an essential feature of the early parkinsonian state. Similar observations and conclusions have been previously made for increased neuronal firing rate in the subthalamic and globus pallidus pars interna nuclei. Accordingly, it is suggested that early parkinsonism may be associated with dynamic changes in basal ganglia output activity leading to reduced movement facilitation that may be an earlier feature of the parkinsonian state.

Keywords: Basal ganglia; Beta oscillations; Oscillatory activity; Parkinson's disease.

Publication types

  • Review

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology
  • Animals
  • Basal Ganglia / pathology*
  • Biological Clocks / drug effects
  • Biological Clocks / physiology*
  • Disease Models, Animal
  • Humans
  • Neurons / drug effects
  • Neurons / physiology*
  • Oxidopamine / toxicity
  • Parkinson Disease / etiology
  • Parkinson Disease / pathology*
  • Rats

Substances

  • Oxidopamine
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine